Related Experiment Video
Updated: Mar 25, 2026

A Microscopic 2,3,5-Triphenyltetrazolium Chloride Assay for Accurate and Reliable Analysis of Myocardial Injury
Published on: November 28, 2025
Takotsubo cardiomyopathy: the pathophysiology
Matthew H Tranter1, Peter T Wright, Markus B Sikkel
1Myocardial Function Section, National Heart and Lung Institute, Imperial College London, Du Cane Road, London W12 0NN, UK.
Takotsubo cardiomyopathy (TTC) is an acute heart failure syndrome linked to excessive catecholamine stimulation, particularly epinephrine. Research suggests using preclinical models to develop treatments for severe cases and prevent recurrence.
Area of Science:
- Cardiology
- Endocrinology
- Pathophysiology
Background:
- Takotsubo cardiomyopathy (TTC) presents as acute heart failure with distinct left ventricular regional wall motion abnormalities.
- Emerging evidence implicates catecholaminergic overstimulation as a primary trigger for TTC and similar conditions.
Purpose of the Study:
- To explore the role of catecholamines, specifically epinephrine, in the pathogenesis of Takotsubo cardiomyopathy.
- To leverage insights from preclinical models for clinical applications in managing severe TTC and preventing relapses.
Main Methods:
- Review of available preclinical models of catecholamine-induced cardiomyopathy.
- Analysis of clinical data supporting the catecholaminergic hypothesis in TTC.
Main Results:
- Catecholaminergic overstimulation, with epinephrine as a key mediator, is strongly supported as the inducer of TTC.
- Preclinical models offer valuable information for understanding TTC mechanisms.
Conclusions:
- Findings support the catecholaminergic hypothesis for Takotsubo cardiomyopathy.
- Preclinical data can guide clinical trials for severe TTC and inform strategies for preventing recurrence in at-risk individuals.
Related Concept Videos
Cardiomyopathy I: Introduction and Classification
Heart Failure II: Pathophysiology
Coronary Artery Disease II: Pathophysiology
Myocarditis I: Introduction
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Pathophysiology of Heart Failure

